TP53 and lung disorder: Our data suggest that the SPP1‐centralized network among integrins, TP53, CD44 and RUNX2 play essential roles in bridging various stages of inflammation‐oriented lung diseases, evidenced by the fact that the network was consistently activated through smokers, smokers with COPD, and COPD smokers with lung cancer.